These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14597686)

  • 1. Ephedrine-type alkaloid-containing dietary supplements and substance dependence.
    Miller SC; Waite C
    Psychosomatics; 2003; 44(6):508-11. PubMed ID: 14597686
    [No Abstract]   [Full Text] [Related]  

  • 2. Ephedrine alkaloids banned from dietary supplements.
    Thompson CA
    Am J Health Syst Pharm; 2004 Apr; 61(8):750-2, 756. PubMed ID: 15127956
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Of snakes and crocodiles". Central side effects caused by nose drops].
    Bielenberg J
    HNO; 1998 Mar; 46(3):276-80. PubMed ID: 9583036
    [No Abstract]   [Full Text] [Related]  

  • 4. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, Has No Adverse Effects Such as Excitation, Insomnia, and Arrhythmias.
    Takemoto H; Takahashi J; Hyuga S; Odaguchi H; Uchiyama N; Maruyama T; Yamashita T; Hyuga M; Oshima N; Amakura Y; Hakamatsuka T; Goda Y; Hanawa T; Kobayashi Y
    Biol Pharm Bull; 2018; 41(2):247-253. PubMed ID: 29386484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History full circle: 'Novel' sympathomimetics in supplements.
    Rasmussen N; Keizers PH
    Drug Test Anal; 2016; 8(3-4):283-6. PubMed ID: 27072841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang).
    Gurley BJ; Gardner SF; White LM; Wang PL
    Ther Drug Monit; 1998 Aug; 20(4):439-45. PubMed ID: 9712471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use.
    Liguori C; Garaci F; Romigi A; Mercuri NB; Marciani MG; Placidi F
    Neurol Sci; 2015 Jul; 36(7):1285-6. PubMed ID: 25527367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hallucinosis in ephedrine addiction].
    Prokop H
    Nervenarzt; 1968 Feb; 39(2):71-5. PubMed ID: 5678234
    [No Abstract]   [Full Text] [Related]  

  • 10. Dietary supplements and stroke.
    McDonald ES; Lane JI
    Mayo Clin Proc; 2005 Mar; 80(3):315. PubMed ID: 15757009
    [No Abstract]   [Full Text] [Related]  

  • 11. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids.
    Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C
    J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent intravenous administration of a high dose of ephedrine.
    Sakuragi T; Yasumoto M; Higa K; Nitahara K
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):121. PubMed ID: 14973819
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Atrial fibrillation and sympathomimetics.
    MacMahon JR
    J Pediatr; 1974 Apr; 84(4):613. PubMed ID: 4857787
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial infarction after over-the-counter use of pseudoephedrine.
    Manini AF; Kabrhel C; Thomsen TW
    Ann Emerg Med; 2005 Feb; 45(2):213-6. PubMed ID: 15671979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction induced by ephedrine alkaloids.
    Enders JM; Dobesh PP; Ellison JN
    Pharmacotherapy; 2003 Dec; 23(12):1645-51. PubMed ID: 14695044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2004; 18(3):95-107. PubMed ID: 15364637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial necrosis and severe biventricular dysfunction in the context of chronic ephedrine abuse].
    Martínez-Quintana E; Rodríguez-González F; Cuba-Herrera J
    Adicciones; 2010; 22(1):25-8. PubMed ID: 20300711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute macular neuroretinopathy following intravenous sympathomimetics.
    O'Brien DM; Farmer SG; Kalina RE; Leon JA
    Retina; 1989; 9(4):281-6. PubMed ID: 2629043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of brown adipose tissue to diet-induced obesity, exercise, dietary restriction and ephedrine treatment.
    Slocum N; Durrant JR; Bailey D; Yoon L; Jordan H; Barton J; Brown RH; Clifton L; Milliken T; Harrington W; Kimbrough C; Faber CA; Cariello N; Elangbam CS
    Exp Toxicol Pathol; 2013 Jul; 65(5):549-57. PubMed ID: 22542811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplement use in the adolescent athlete.
    DesJardins M
    Curr Sports Med Rep; 2002 Dec; 1(6):369-73. PubMed ID: 12831686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.